By Counterforce Health Team in Berinert (C1-esterase inhibitor, IV) —

How to Get Berinert (C1-esterase inhibitor, IV) Covered by Humana in New Jersey: Complete Prior Authorization Guide

Answer Box: Getting Berinert Covered by Humana in New Jersey

Berinert requires prior authorization from Humana for hereditary angioedema (HAE) acute attacks only—not prophylaxis. You'll need documented HAE diagnosis, step therapy completion (trying icatibant or ecallantide first), and specialist approval. If denied, New Jersey's Independent Health Care Appeals Program (IHCAP) through Maximus provides binding external review within 4 months. Start today: Gather HAE lab results (low C4, C1-INH levels) and prior treatment records, then submit PA request through Humana's provider portal.

Table of Contents

  1. Humana's Coverage Policy for Berinert
  2. Medical Necessity Requirements
  3. Step Therapy and Required Alternatives
  4. Prior Authorization Process
  5. Common Denial Reasons and Solutions
  6. Appeals Process in New Jersey
  7. Cost Assistance Programs
  8. Clinician Corner: Documentation Checklist
  9. FAQ

Humana's Coverage Policy for Berinert

Humana covers Berinert (C1-esterase inhibitor, IV) exclusively for on-demand treatment of acute HAE attacks—never for routine prophylaxis. The medication requires prior authorization across all Humana plan types, including Medicare Advantage and commercial plans.

Coverage at a Glance

Requirement Details Source
Prior Authorization Required for all plans Humana PA Lists
Formulary Status Specialty tier, non-preferred Humana Drug Lists
Step Therapy Must try icatibant or ecallantide first Humana Clinical Review
Indication Acute HAE attacks only FDA Label
Dosing Limit 20 IU/kg per attack Berinert Prescribing Info
Site of Care Hospital, infusion center, or home Plan-specific

Humana's PA denial rate for specialty medications is approximately 3.5% as of 2023—among the lowest of major insurers—but denials often stem from incomplete documentation rather than medical necessity concerns.

Medical Necessity Requirements

HAE Diagnosis Documentation

Insurance approval requires clear diagnostic evidence of hereditary angioedema:

Laboratory Evidence Required:

  • C4 Level: Must be low (<50% of normal reference values)
  • C1-INH Antigenic Level: Low for Type I HAE; normal/elevated for Type II
  • C1-INH Functional Level: Low (<50% of normal for both types)
  • C1q Level: Typically normal (helps rule out acquired angioedema)

Clinical Documentation:

  • History of recurrent angioedema without urticaria
  • Episodes lasting >6 hours with laryngeal edema or abdominal pain
  • Family history (supportive but not mandatory)
  • Lack of response to antihistamines
Tip: Lab values must reference specific normal ranges from the testing facility. Generic statements like "abnormal" won't satisfy Humana's review.

ICD-10 Codes for HAE

  • D84.1 - Defects in the complement system (primary code for HAE)
  • T78.3 - Angioneurotic edema (for acute attacks)

Step Therapy and Required Alternatives

Humana requires documented trial and failure (or contraindication) of preferred first-line treatments before approving Berinert.

Required First-Line Alternatives

  1. Icatibant (Firazyr) - Subcutaneous bradykinin receptor antagonist
  2. Ecallantide (Kalbitor) - Subcutaneous kallikrein inhibitor
  3. Ruconest - Recombinant C1-inhibitor (contraindicated in rabbit allergy)

Medical Exceptions to Step Therapy

You can bypass step therapy with documentation of:

  • Contraindications: Allergies, drug interactions, or medical conditions preventing use
  • Prior Failures: Previous treatment attempts with inadequate response or intolerable side effects
  • Clinical Urgency: Severe laryngeal attacks requiring immediate IV access
Note: "Patient preference" alone won't override step therapy requirements. Clinical justification is essential.

Prior Authorization Process

Step-by-Step: Fastest Path to Approval

  1. Gather Required Documentation (Patient/Clinic)
    • HAE lab results with reference ranges
    • Prior treatment history and outcomes
    • Specialist consultation notes
    • Current attack frequency/severity
  2. Submit PA Request (Provider)
    • Use Humana Provider Portal (preferred)
    • Alternative: CoverMyMeds platform
    • Include complete clinical justification letter
  3. Await Initial Decision (7-14 days standard)
    • Humana processes 85% of electronic requests within 1 business day
    • Complex cases may take full 14-day regulatory timeline
  4. Address Any Information Requests (Provider)
    • Respond within 5 business days to avoid delays
    • Common requests: additional lab values, specialist letters
  5. Receive Approval or Denial
    • Approvals typically valid for 6-12 months
    • Denials include specific reason codes and appeal instructions

Required Documentation Checklist

  • HAE diagnosis with lab confirmation
  • Prescription from allergist/immunologist
  • Step therapy completion or exception justification
  • Attack frequency and severity documentation
  • Weight-based dosing calculation (20 IU/kg)
  • Site of care preference with rationale

Common Denial Reasons and Solutions

Denial Reason How to Overturn Required Documentation
Incomplete HAE diagnosis Submit full lab panel C4, C1-INH levels with reference ranges
Missing step therapy Document prior treatments Prescription records, failure/intolerance notes
Prophylactic use requested Clarify on-demand indication Attack-based dosing schedule
Quantity limits exceeded Justify dosing frequency Attack logs, specialist letter
Non-specialist prescriber Transfer to appropriate provider Allergist/immunologist consultation

From Our Advocates

"We've seen Humana approvals turn around quickly when the initial submission includes both the diagnostic labs and a detailed letter from the prescribing specialist explaining why first-line treatments weren't suitable. This composite approach—combining complete documentation with clear clinical narrative—significantly reduces back-and-forth requests for additional information."

Appeals Process in New Jersey

Internal Appeals with Humana

Timeline: 65 days from denial for Medicare members; 30 days for commercial plans

How to Appeal:

  • Online: Humana member portal
  • Phone: Number on denial letter or member ID card
  • Mail: Address provided in denial notice

Required Documents:

  • Original denial letter
  • Additional clinical documentation
  • Prescriber letter addressing denial reasons

New Jersey External Review (IHCAP)

If Humana's internal appeal is unsuccessful, New Jersey's Independent Health Care Appeals Program provides binding external review.

Eligibility:

  • Must complete Humana's internal appeals process first
  • Available for medical necessity denials
  • Must file within 4 months of final internal denial

How to Submit:

  • Online: Maximus NJ IHCAP Portal
  • Fax: (585) 425-5296
  • Mail: Maximus Federal, Attn: State Appeals/NJ IHCAP, 3750 Monroe Avenue, Suite 705, Pittsford, NY 14534

Timeline:

  • Preliminary review: 5 business days
  • Full review decision: Within 45 days
  • Expedited reviews available for urgent cases

Cost: Free to patients (insurers pay all fees)

Important: IHCAP decisions are binding on Humana. If the external reviewer determines Berinert is medically necessary, Humana must provide coverage.

For questions about the external review process, call the IHCAP hotline at 1-888-393-1062.

Cost Assistance Programs

CSL Behring Patient Support

Berinert Access Program provides:

  • Free medication for uninsured patients
  • Copay assistance for insured patients
  • Prior authorization support services

Eligibility Requirements:

  • Confirmed HAE diagnosis
  • Prescription for FDA-approved indication
  • Financial need documentation

How to Apply: Contact CSL Behring patient support directly through their official patient assistance program (verify current contact information with CSL Behring).

Additional Resources

  • National Organization for Rare Disorders (NORD): Rare Disease Financial Assistance Programs
  • HealthWell Foundation: Copay assistance for rare diseases
  • Patient Advocate Foundation: Insurance appeals assistance

Clinician Corner: Documentation Checklist

Medical Necessity Letter Template

Your letter to Humana should address:

  1. Patient Demographics and Diagnosis
    • Age, weight (for dosing calculation)
    • HAE type with supporting lab values
    • ICD-10 codes: D84.1, T78.3
  2. Clinical History
    • Attack frequency, severity, and location
    • Previous treatments tried and outcomes
    • Emergency department visits or hospitalizations
  3. Step Therapy Justification
    • Specific reasons why icatibant/ecallantide are inappropriate
    • Contraindications or prior treatment failures
    • Clinical urgency factors
  4. Treatment Plan
    • On-demand use only (not prophylactic)
    • 20 IU/kg dosing per attack
    • Site of care and administration plan
  5. Supporting Evidence

Key Clinical Guidelines to Reference

  • World Allergy Organization (WAO) HAE Guidelines
  • American Academy of Allergy, Asthma & Immunology (AAAAI) Practice Parameters
  • FDA Prescribing Information for Berinert

Frequently Asked Questions

Q: How long does Humana's prior authorization take in New Jersey? A: Standard requests: 7-14 days. Humana processes 85% of electronic submissions within 1 business day, with complex cases taking the full regulatory timeline.

Q: Can I get expedited approval for urgent HAE attacks? A: Yes. Request expedited review if delay would cause serious harm. Expedited decisions are typically made within 24-72 hours.

Q: What if Berinert isn't on Humana's formulary? A: Submit a formulary exception request with medical necessity documentation. Non-formulary drugs can be covered when medically necessary.

Q: Does step therapy apply if I failed these medications with a different insurer? A: Yes, but document the prior failures thoroughly. Humana will consider out-of-network or previous insurance treatment history.

Q: Can I appeal if my doctor isn't an allergist or immunologist? A: Humana typically requires specialist prescribing for HAE medications. Consider obtaining a consultation or referral.

Q: How often do I need to renew prior authorization? A: Typically every 6-12 months, depending on your specific plan. Renewal requires updated clinical documentation.

Q: What happens if I need Berinert while traveling outside New Jersey? A: Prior authorization follows you anywhere in the US. Ensure you have approval documentation and consider emergency protocols for out-of-state attacks.

About Counterforce Health

Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals. Our platform analyzes denial letters, plan policies, and clinical notes to create targeted, evidence-backed appeals that meet payer-specific requirements. For complex cases like Berinert coverage, we provide the clinical documentation and procedural expertise needed to navigate Humana's approval process effectively.

When you're facing a Berinert denial from Humana, Counterforce Health can help identify the specific denial basis—whether it's PA criteria, step therapy, or medical necessity concerns—and draft a point-by-point rebuttal aligned with Humana's own coverage policies.

Sources & Further Reading

This guide is for informational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific coverage decisions. For additional help with insurance appeals in New Jersey, contact the NJ Department of Banking and Insurance Consumer Hotline at 1-800-446-7467.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.